| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910464954403321 |
|
|
Autore |
Lule Elizabeth |
|
|
Titolo |
The fiscal dimensions of HIV/AIDS in Botswana, South Africa, Swaziland, and Uganda [[electronic resource] /] / by Elizabeth Lule and Markus Haacker |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, D.C., : World Bank, 2011 |
|
|
|
|
|
|
|
ISBN |
|
1-283-44659-6 |
9786613446596 |
0-8213-8808-8 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (312 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
AIDS (Disease) - Economic aspects - Africa, Southern |
AIDS (Disease) - Economic aspects - Uganda |
HIV infections - Economic aspects - Africa, Southern |
HIV infections - Economic aspects - Uganda |
HIV infections - Government policy - Africa, Southern - Finance |
HIV infections - Government policy - Uganda - Finance |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Contents; Foreword; Acknowledgments; Abbreviations; Overview; Methodology; Country Summaries; Conclusions; Notes; References; 1 Introduction; Background; Methodology; Notes; References; 2 Botswana; I. Introduction; II. The Impact of HIV/AIDS in Botswana; III. HIV/AIDS and Public Finance; IV. Modeling the Fiscal Dimension of HIV/AIDS; V. Conclusions; VI. Annex; Notes; References; 3 South Africa; I. Introduction; II. The Impact of HIV/AIDS in South Africa; III. Stocktaking: HIV/AIDS and Public Finance; IV. Projecting the Fiscal Costs of HIV/AIDS; V. HIV/AIDS as a Fiscal Liability |
VI. ConclusionsVII. Annex; Notes; References; 4 Swaziland; I. Introduction; II. The Impact of HIV/AIDS in Swaziland; III. Stocktaking-HIV/AIDS and Public Finance; IV. The Fiscal Dimension of HIV/AIDS; V. Conclusions; VI. Annex; Notes; References; 5 Uganda; I. Introduction; II. The Impact of HIV/AIDS in Uganda; III. HIV/AIDS and Public Finance; IV. |
|
|
|
|
|
|
|
|
|
|
|
The Fiscal Dimension of HIV/AIDS; V. Conclusions; VI. Annex; Notes; References; Index; Figures; 0.1 Botswana: Fiscal Costs of HIV/AIDS (2010-30); 0.2 External Financing of HIV/AIDS Programs across Countries |
0.3 Botswana: Costs of One Additional Infection0.4 Botswana: Fiscal Costs of HIV/AIDS, 2010-30; 0.5 South Africa: Evolution of the HIV Epidemic; 0.6 South Africa: Fiscal Costs of HIV/AIDS, "Narrow NSP" Scenario, 2007-31; 0.7 South Africa: Fiscal Costs of HIV/AIDS, "Expanded NSP" Scenario, 2007-31; 0.8 South Africa: Costs of Additional Infection Occurring in 2010, "Narrow NSP" Scenario; 0.9 South Africa: Costs of Additional Infection Occuring in 2010, "Expanded NSP" Scenario; 0.10 South Africa: Fiscal Costs of HIV/AIDS, "Commitment" Basis, "Narrow NSP" Scenario, 2010-31 |
0.11 South Africa: Fiscal Costs of HIV/AIDS, "Commitment" Basis, "Expanded NSP" Scenario, 2010-310.12 Swaziland: The Fiscal Costs of HIV/AIDS, 2010-30; 0.13 Swaziland: External HIV/AIDS Support; 0.14 Swaziland: Costs of Additional Infection Occurring in 2010; 0.15 Swaziland: Fiscal Costs of HIV/AIDS; 0.16 Uganda: Mortality by Sex and Age; 0.17 Uganda: Projected Costs of HIV/AIDS Program, 2008-25; 0.18 Uganda: Domestically and Externally Financed HIV/AIDS Spending; 0.19 Uganda: Actual Spending and Costs Incurred by New HIV Infections, 2010-30 |
0.20 Uganda: Change in Value of Spending Commitments, 2010-301.1 Southern African Development Community: GDP Growth, 2005-12; 1.2 Macroeconomic Trends, Advanced Economies, 2005-12; 1.3 Demographic and Epidemiological Module; 2.1 Evolution of the HIV Epidemic; 2.2 HIV Prevalence by Age Group, 2004 and 2008; 2.3 Access to Antiretroviral Therapy, 2004-09; 2.4 HIV/AIDS, Mortality, and Morbidity; 2.5 Survival Rates from Age 0 by Sex, 2005-10; 2.6 Life Expectancy and GDP per Capita, 2008; 2.7 Human Development Index and Underlying Factors, Seven Countries; 2.8 Fiscal Outlook, 2008-30 |
2.9 Health Expenditures by Source of Financing, 1995-2008 |
|
|
|
|
|
|
Sommario/riassunto |
|
HIV/AIDS continues to take a tremendous toll on the populations of many countries, especially in sub-Saharan Africa. In some countries with high HIV prevalence rates, life expectancy has declined by more than a decade and in a few cases by more than two decades. Even in countries with HIV prevalence of around 5 percent (close to the average for sub-Saharan Africa), the epidemic can reverse gains in life expectancy and other health outcomes achieved over one or two decades.This volume highlights work conducted under the umbrella of a World Bank work program on "The Fiscal Dimension of HIV/AIDS, |
|
|
|
|
|
|
|
| |